Doximity Director Sells $354K in Stock via 10b5-1 Plan
Doximity, Inc.
Subscribe to track DOCS
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Doximity Director Sells $354K in Stock
Company: Doximity, Inc. (DOCS) Form: 4 | Filed: 2025-10-14 Significance: Medium
Insider: Benjamin Regina M. Title: null | Relationship: Director
Transaction: • Type: Sale • Shares: 5,000 • Price: $70.84 • Value: $354,200 • Owned After: 19,839
Key Insight: The sale was executed automatically under a pre-arranged Rule 10b5-1 trading plan, which reduces the immediate signal of the transaction as it was not a spontaneous decision.
Market Context: This transaction involved exercising stock options, converting them to Class A shares, and then selling them, a common method for insiders to realize compensation.
This is PUBLIC SEC data for educational purposes. Not investment advice.
Comprehensive Analysis
SEC Filing Analysis: Doximity, Inc. (DOCS)
Executive Summary
- Trading Significance: Medium
- Key Takeaway: A Director at Doximity, Inc. sold 5,000 shares of Class A Common Stock for a total of $354,200. The sale was conducted under a pre-established Rule 10b5-1 trading plan, indicating it was a planned liquidity event rather than a reaction to recent market or company developments.
- Market Impact: The pre-planned nature of the sale is expected to have a neutral to slightly negative impact. While insider sales can be viewed negatively, 10b5-1 plans are common for executive compensation and diversification, mitigating much of the bearish sentiment.
Company Information
| Field | Value |
|---|---|
| Company | Doximity, Inc. |
| Ticker Symbol | DOCS |
| CIK | 0001516513 |
| Industry | SERVICES-COMPUTER PROGRAMMING SERVICES [7371] |
Insider Information
| Field | Value |
|---|---|
| Name | Benjamin Regina M. |
| CIK | 0001594511 |
| Title/Position | null |
| Relationship | Director |
Transaction Details
This filing reports a multi-step transaction culminating in a sale. The key market-facing event is the sale of Class A Common Stock.
| Field | Value |
|---|---|
| Form Type | 4 |
| Transaction Date | 2025-10-10 |
| Transaction Code | S (Sale) |
| Security Type | Class A Common Stock |
| Shares Involved | 5,000 |
| Price Per Share | $70.84 |
| Total Value | $354,200.00 |
| Shares Owned After | 19,839 |
| Ownership Type | Direct |
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: The sale's execution under a Rule 10b5-1 plan, adopted in February 2025, significantly dampens any negative interpretation. The market generally views such planned sales as less indicative of an insider's current outlook on the company's future performance.
Volume & Sentiment
- Expected Volume Impact: Minimal. The trade size is not substantial enough to significantly impact daily trading volume.
- Sentiment Indicator: Neutral. The transparency provided by the 10b5-1 plan footnote prevents this from being a bearish signal. It's seen as a routine executive financial planning activity.
Investment Insights
Positive Market Indicators
- The insider still holds a meaningful position of 19,839 shares after the sale, indicating continued alignment with shareholder interests.
- The transaction is part of a structured plan, not a panic sell.
Risk Factors
- Any insider sale, even if planned, can be perceived as profit-taking and may contribute to overhead supply in the stock.
- The sale follows the exercise of options with a very low strike price ($2.21), representing a significant gain for the insider.
Key Takeaways
- Planned Liquidity Event: This is a classic "exercise-and-sell" transaction conducted under a 10b5-1 plan, primarily for diversification or financial planning.
- Not a Negative Signal: Due to the pre-planned nature, this sale should not be interpreted as the director having a negative near-term outlook on Doximity.
- Underlying Option Exercise: The sale was facilitated by exercising stock options granted in 2020, realizing value from long-term incentive compensation.
Contextual Analysis
Timing Significance
The transaction was executed on October 10, 2025, based on a plan adopted nearly eight months prior (February 26, 2025). This long lead time divorces the sale from any immediate, non-public information the director might possess.
Transaction Context
The filing details a sequence of events all occurring on the same day:
- Exercise (Code M): The insider exercised options to acquire 5,000 shares of Class B Common Stock at a price of $2.21 per share.
- Conversion (Code C): The newly acquired 5,000 Class B shares were immediately converted into 5,000 shares of Class A Common Stock on a one-for-one basis.
- Sale (Code S): The 5,000 Class A shares were then sold on the open market at $70.84 per share. This entire process is automated and common for cashing out vested options.
As per Footnote F2, the sale was automatic and pursuant to the Rule 10b5-1 plan.
Company Context
An analysis of Doximity's performance, recent earnings reports, and industry trends around the transaction date would provide further context, but the 10b5-1 plan remains the most critical factor in interpreting this specific filing.
Risk Assessment
Risk Level: Low
Risk Factors
- Perception Risk: Some retail investors may react negatively to any insider sale regardless of context.
- Overhang Risk: Consistent sales from multiple insiders under 10b5-1 plans could create a perception of a continued selling pressure.
Market Considerations
- The existence of a 10b5-1 plan is a defense against allegations of trading on material non-public information.
- The market has become adept at distinguishing between planned and opportunistic insider sales.
IMPORTANT DISCLAIMER: This analysis is for informational purposes only and is not intended as investment advice. The information presented is based on publicly available SEC filings and should not be construed as a recommendation to buy, sell, or hold any securities. Past performance does not guarantee future results. All investments carry risk, including the potential loss of principal. Please consult with a qualified financial advisor before making any investment decisions.
Analysis generated on 2025-10-14 | Data source: SEC EDGAR
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.
